| Chaya R Weisenfeld, NP | |
|
1352 River Ave, Lakewood, NJ 08701-5646 | |
| (732) 370-5100 | |
| Not Available |
| Full Name | Chaya R Weisenfeld |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 6 Years |
| Location | 1352 River Ave, Lakewood, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073071916 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 26NJ00885300 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Monmouth Medical Center - Southern Campus | Lakewood, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ocean County Internal Medicine Associates, Pa | 5193763126 | 8 |
| Hudson Md Group | 6103240478 | 67 |
News Archive
Postpartum hemorrhage with a first pregnancy does not have a detrimental effect on second pregnancies, research shows.
Dr. Rong Zhang, a researcher at the Institute for Exercise and Environmental Medicine at Texas Health Presbyterian Hospital Dallas, has been awarded a four-year grant from the National Institute on Aging to research the connection between exercise and brain function as people age.
Nanoparticle delivery of diphtheria toxin-encoding DNA that expresses selectively in ovarian cancer cells reduced the burden of ovarian tumors in mice, and researchers expect that this therapy could be tested in humans with advanced ovarian cancer within 18 to 24 months, according to a report in Cancer Research. If additional tests are successful, these finding could lead to a new treatment for ovarian cancer, which now causes more than 15,000 deaths each year in the United States. Because it is usually diagnosed at a relatively late stage, ovarian cancer is one of the most deadly forms of the disease.
Two scientific poster presentations that demonstrate the infection prevention capabilities of InVision-Plus® with Neutral Advantage™ technology were featured at the annual conference of the Society for Healthcare Epidemiology of America.
Final results are published from an evaluation of 42 patients treated with the immune checkpoint inhibitor nivolumab in the large multi-arm precision medicine trial, NCI-Molecular Analysis for Therapy Choice (NCI-MATCH or EAY131).
› Verified 3 days ago
| Entity Name | Ocean County Internal Medicine Associates, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558445403 PECOS PAC ID: 5193763126 Enrollment ID: O20050420001059 |
News Archive
Postpartum hemorrhage with a first pregnancy does not have a detrimental effect on second pregnancies, research shows.
Dr. Rong Zhang, a researcher at the Institute for Exercise and Environmental Medicine at Texas Health Presbyterian Hospital Dallas, has been awarded a four-year grant from the National Institute on Aging to research the connection between exercise and brain function as people age.
Nanoparticle delivery of diphtheria toxin-encoding DNA that expresses selectively in ovarian cancer cells reduced the burden of ovarian tumors in mice, and researchers expect that this therapy could be tested in humans with advanced ovarian cancer within 18 to 24 months, according to a report in Cancer Research. If additional tests are successful, these finding could lead to a new treatment for ovarian cancer, which now causes more than 15,000 deaths each year in the United States. Because it is usually diagnosed at a relatively late stage, ovarian cancer is one of the most deadly forms of the disease.
Two scientific poster presentations that demonstrate the infection prevention capabilities of InVision-Plus® with Neutral Advantage™ technology were featured at the annual conference of the Society for Healthcare Epidemiology of America.
Final results are published from an evaluation of 42 patients treated with the immune checkpoint inhibitor nivolumab in the large multi-arm precision medicine trial, NCI-Molecular Analysis for Therapy Choice (NCI-MATCH or EAY131).
› Verified 3 days ago
| Entity Name | Hudson Md Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497301998 PECOS PAC ID: 6103240478 Enrollment ID: O20200720001687 |
News Archive
Postpartum hemorrhage with a first pregnancy does not have a detrimental effect on second pregnancies, research shows.
Dr. Rong Zhang, a researcher at the Institute for Exercise and Environmental Medicine at Texas Health Presbyterian Hospital Dallas, has been awarded a four-year grant from the National Institute on Aging to research the connection between exercise and brain function as people age.
Nanoparticle delivery of diphtheria toxin-encoding DNA that expresses selectively in ovarian cancer cells reduced the burden of ovarian tumors in mice, and researchers expect that this therapy could be tested in humans with advanced ovarian cancer within 18 to 24 months, according to a report in Cancer Research. If additional tests are successful, these finding could lead to a new treatment for ovarian cancer, which now causes more than 15,000 deaths each year in the United States. Because it is usually diagnosed at a relatively late stage, ovarian cancer is one of the most deadly forms of the disease.
Two scientific poster presentations that demonstrate the infection prevention capabilities of InVision-Plus® with Neutral Advantage™ technology were featured at the annual conference of the Society for Healthcare Epidemiology of America.
Final results are published from an evaluation of 42 patients treated with the immune checkpoint inhibitor nivolumab in the large multi-arm precision medicine trial, NCI-Molecular Analysis for Therapy Choice (NCI-MATCH or EAY131).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Chaya R Weisenfeld, NP 207 1st St Apt 407, Lakewood, NJ 08701-3368 Ph: (248) 798-9092 | Chaya R Weisenfeld, NP 1352 River Ave, Lakewood, NJ 08701-5646 Ph: (732) 370-5100 |
News Archive
Postpartum hemorrhage with a first pregnancy does not have a detrimental effect on second pregnancies, research shows.
Dr. Rong Zhang, a researcher at the Institute for Exercise and Environmental Medicine at Texas Health Presbyterian Hospital Dallas, has been awarded a four-year grant from the National Institute on Aging to research the connection between exercise and brain function as people age.
Nanoparticle delivery of diphtheria toxin-encoding DNA that expresses selectively in ovarian cancer cells reduced the burden of ovarian tumors in mice, and researchers expect that this therapy could be tested in humans with advanced ovarian cancer within 18 to 24 months, according to a report in Cancer Research. If additional tests are successful, these finding could lead to a new treatment for ovarian cancer, which now causes more than 15,000 deaths each year in the United States. Because it is usually diagnosed at a relatively late stage, ovarian cancer is one of the most deadly forms of the disease.
Two scientific poster presentations that demonstrate the infection prevention capabilities of InVision-Plus® with Neutral Advantage™ technology were featured at the annual conference of the Society for Healthcare Epidemiology of America.
Final results are published from an evaluation of 42 patients treated with the immune checkpoint inhibitor nivolumab in the large multi-arm precision medicine trial, NCI-Molecular Analysis for Therapy Choice (NCI-MATCH or EAY131).
› Verified 3 days ago
Cheryl S. Ochs, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1771 Madison Ave, Lakewood, NJ 08701 Phone: 732-364-2144 | |
Shaindel Parnes, APN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1771 Madison Ave, Lakewood, NJ 08701 Phone: 732-364-2144 | |
Rochelle Travis, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 25 Bay Hill Rd, Lakewood, NJ 08701 Phone: 848-245-4347 | |
Ms. Lara Duffy, A.P.N. Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1 Route 70, Lakewood, NJ 08701 Phone: 732-901-0211 Fax: 732-901-0199 | |
Mrs. Shira Wurzburger, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 103 Tudor Ct, Lakewood, NJ 08701 Phone: 845-641-3463 | |
Rosie Tesler, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 400 Madison Ave, Lakewood, NJ 08701 Phone: 732-364-7770 | |
Ahuva Hollander, CPNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 400 Madison Ave, Lakewood, NJ 08701 Phone: 732-364-7770 |